Stroke Gait RehabilitationNCT07192484
Effects of Kinesio Taping in Subacute Stroke Patients
A study testing KT group and Conventional group in people with Stroke Gait Rehabilitation, run by Fooyin University.
Trial summary
A study was designed to investigate the effects of KT on gait ability, balance, and neuromuscular functions in subacute stroke patients with foot drop. The study aims to evaluate the immediate and short-term effects of KT on gait ability, balance, and neuromuscular function in subacute stroke patients with foot drop. Read more about this study
- Who is it for?
- Ages 20 to 80 years
- Conditions the study is for
- Stroke Gait Rehabilitation
- What is being tested?
- KT group and Conventional group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 15 Sep 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age between 20 and 80 years;
- First unilateral stroke;
- Stroke onset between at least 1 week and 1 year;
- Ability to continuously walk 10 meters with or without assistive devices;
- Presence of foot drop on the affected side during the swing phase due to insufficient ankle dorsiflexion;
- Brunnstrom stage of the affected lower limb ≥ 3;
- Presence of mild spasticity in the affected ankle plantar flexors, with a Modified Ashworth Scale score ≤ 2;
- Ability to follow simple commands
Who cannot join
- Other neurological disorders or unstable medical conditions;
- Skin allergies that interfere with the use of tape;
- Visual field defects;
- Cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score < 24;
- Pusher syndrome;
- Ankle contracture;
Show all 9Show fewer
- Hemispatial neglect;
- Poorly controlled hypertension or cardiovascular disease;
- Any other disease, apart from stroke, that may affect balance or gait.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effects of Kinesio Taping on Gait Ability, Balance, and Neuromuscular Functions in Subacute Stroke Patients With Foot Drop
A study was designed to investigate the effects of KT on gait ability, balance, and neuromuscular functions in subacute stroke patients with foot drop. The study aims to evaluate the immediate and short-term effects of KT on gait ability, balance, and neuromuscular function in subacute stroke patients with foot drop. A total of 60 participants will be recruited and randomly assigned to either a control group (conventional physical therapy) or an experimental group (receiving additional KT). Both groups will receive 30 minutes of daily physical therapy. The experimental group will undergo an initial assessment before KT application, which includes (1) activation of the dorsiflexor muscles, (2) reduction of plantar flexor spasticity, and (3) stabilization of the ankle in an everted position. After taping, a second assessment will be conducted immediately, and the tape will stay applied to patient's limb for two days, followed by a third assessment. The control group will be assessed only before the intervention and after two days. Primary outcome measures include gait ability (10-meter walk test, laboratory gait parameters, and joint angles and electromyographic activity during walking). Secondary outcomes include balance (Functional reach test, Timed Up and Go test, and Activities-specific Balance Confidence Scale) and neuromuscular function assessments (muscle strength, joint range of motion, spasticity, and proprioception). This project aims to establish and validate a clinically applicable and effective KT protocol as an adjunctive gait training method for subacute stroke patients with foot drop. By enhancing independent and safe walking, this intervention may facilitate the early return to normal daily activities for stroke survivors.
- Conditions
- Stroke Gait Rehabilitation
- Being tested
- KT group, Conventional group
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KT groupBehavioural
Receiving additional KT
Conventional groupBehavioural
Conventional physical therapy
| Study group | Role | What they receive |
|---|---|---|
| KT group | Experimental | Receiving additional Kinesio taping Receives: Behavioral: KT group |
| Control group | Other | Conventional physical therapy Receives: Behavioral: Conventional group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gait ability - 10 meter walk test
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The examiner uses a stopwatch to record the time taken to walk the middle 10 meters, and then divides the distance (10 meters) by the time to calculate the walking speed.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Speed (m/s)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Speed (m/s) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Cadence (steps/minute)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Cadence (steps/minute) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Stride length (m)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Stride length (m) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Step length (m)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Step length (m) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Percentages of stance phase (%)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Percentages of stance phase (%) will be recorded using the commercially available portable gait analysis system (Gait Up)
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Percentages of swing phase (%)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Percentages of swing phase (%) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - Gait symmetry (%)
Gait symmetry (%) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - first maximum toe clearance (cm)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The first maximum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - second maximum toe clearance (cm)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The second maximum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait ability - minimum toe clearance (cm)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The minimum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Ankle joint range (degrees) during walking
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Ankle joint range (degrees) during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
EMG activity (µV) of tibialis anterior during walking
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. EMG activity (µV) of tibialis anterior during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
EMG activity (µV) of gastrocnemius during walking
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. EMG activity (µV) of gastrocnemius during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Secondary outcomes (7)
Functional reach test
Participant is asked to stand by the wall without leaning against it, with hands clenched into fists and arms raised forward to shoulder height with the shoulder joints flexed at 90 degrees. The examiner records the position of the participant's third metacarpal bone as the starting point. Then, while keeping both arms raised, the participant is instructed to lean the body forward as far as possible. The examiner records the farthest position of the third metacarpal bone as the endpoint. The test result is determined by subtracting the starting point from the endpoint.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Timed Up and Go test
In this test, a distance of three meters is marked on the floor, with a chair equipped with armrests and a backrest placed at one end. The participant is first asked to sit on the chair with their back against the backrest. When the examiner gives the start signal, the participant is required to rise from the chair, walk forward three meters at their usual walking speed to the marked line, turn around, walk back, and sit down on the chair again. The time taken from the moment the examiner gives the start signal until the participant has seated themselves back on the chair is recorded using a stopwatch.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Activities-specific Balance Confidence Scale
This scale is a questionnaire designed to assess the participant's self-confidence in maintaining balance and avoiding falls in 16 situations that may be encountered in the community. Each of the 16 items is scored starting from 0, where 0 indicates no confidence at all. Scores are given in increments of 10, up to a maximum of 100, with 100 representing complete confidence.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Muscle strength
Muscle strength of the ankle dorsiflexors will be measured using a handheld dynamometer (MicroFET3; Hoggan Health Industries, Salt Lake City, UT, USA). The participant lies supine on a treatment table with both feet hanging over the edge. The dynamometer is positioned on the dorsal aspect of the metatarsophalangeal joints to assess dorsiflexor strength. During the test, the examiner holds the dynamometer stationary while the participant exerts maximal force against it. Each contraction is sustained for 5 seconds, repeated three times, with a 10-second rest interval between trials. The mean value of the peak force obtained across the three trials will be used for analysis.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Joint range of motion
Active range of motion (ROM) of ankle dorsiflexion and plantarflexion will be measured using a goniometer. The participant is positioned in a high sitting posture. The fulcrum of the goniometer is placed over the lateral malleolus of the ankle, with the stationary arm aligned parallel to the lateral aspect of the fibula and the moving arm aligned parallel to the fifth metatarsal. Starting from the neutral position at 0°, the participant is instructed to perform maximal active dorsiflexion followed by plantarflexion.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Spasticity
The degree of ankle muscle spasticity will be assessed using the Modified Ashworth Scale (MAS). During the test, the joint is passively moved through its range of motion with a quick stretch to determine the presence of resistance. The scale consists of six grades (0, 1, 1+, 2, 3, 4), where a score of 0 indicates normal muscle tone and higher scores represent increasing severity of spasticity.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Proprioception
Proprioception will be assessed using the inclinometer function of the muscle strength and angle measurement device (MicroFET3; Hoggan Health Industries, Salt Lake City, UT, USA) on the affected foot. The participant is seated on a treatment table with eyes closed and the knee extended, with the ankle positioned at 0° dorsiflexion as the starting position. The inclinometer is placed on the dorsum of the foot. The examiner passively positions the ankle to a target dorsiflexion or plantarflexion angle, and the participant is instructed to maintain this position for 10 seconds before returning to the starting position. The participant is then asked to actively reproduce the target angle. Both the examiner-set angle and the participant-reproduced angle are recorded, and the error between the two values is used to represent proprioceptive acuity.
Measured: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2025
- Study start15 Sep 2025 (estimated)
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke Gait RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fooyin University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07192484
- Sponsor's protocol ID
- KSVGH25-CT6-22
- Status last verified
- Sep 2025
- First submitted
- 4 Sep 2025
- Last updated
- 25 Sep 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Kinesio Taping on Gait Ability, Balance, and Neuromuscular Functions in Subacute Stroke Patients With Foot Drop
- ClinicalTrials.gov ID
- NCT07192484
- Acronym / sponsor ID
- KSVGH25-CT6-22
- Conditions
- Stroke Gait Rehabilitation
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Fooyin UniversityUniversity, hospital or other
- Study start
- 15 Sep 2025 (estimated)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 25 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A study was designed to investigate the effects of KT on gait ability, balance, and neuromuscular functions in subacute stroke patients with foot drop. The study aims to evaluate the immediate and short-term effects of KT on gait ability, balance, and neuromuscular function in subacute stroke patients with foot drop. A total of 60 participants will be recruited and randomly assigned to either a control group (conventional physical therapy) or an experimental group (receiving additional KT). Both groups will receive 30 minutes of daily physical therapy. The experimental group will undergo an initial assessment before KT application, which includes (1) activation of the dorsiflexor muscles, (2) reduction of plantar flexor spasticity, and (3) stabilization of the ankle in an everted position. After taping, a second assessment will be conducted immediately, and the tape will stay applied to patient's limb for two days, followed by a third assessment. The control group will be assessed only before the intervention and after two days. Primary outcome measures include gait ability (10-meter walk test, laboratory gait parameters, and joint angles and electromyographic activity during walking). Secondary outcomes include balance (Functional reach test, Timed Up and Go test, and Activities-specific Balance Confidence Scale) and neuromuscular function assessments (muscle strength, joint range of motion, spasticity, and proprioception). This project aims to establish and validate a clinically applicable and effective KT protocol as an adjunctive gait training method for subacute stroke patients with foot drop. By enhancing independent and safe walking, this intervention may facilitate the early return to normal daily activities for stroke survivors.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| KT group | Experimental | Behavioral: KT groupReceiving additional Kinesio taping |
| Control group | Other | Behavioral: Conventional groupConventional physical therapy |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Age between 20 and 80 years;
- First unilateral stroke;
- Stroke onset between at least 1 week and 1 year;
- Ability to continuously walk 10 meters with or without assistive devices;
- Presence of foot drop on the affected side during the swing phase due to insufficient ankle dorsiflexion;
Key exclusion criteria (9 listed)
- Other neurological disorders or unstable medical conditions;
- Skin allergies that interfere with the use of tape;
- Visual field defects;
- Cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score < 24;
- Pusher syndrome;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KT groupReceiving additional KT | Behavioural | KT group |
| Conventional groupConventional physical therapy | Behavioural | Control group |
Primary outcome
Gait ability - 10 meter walk test
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The examiner uses a stopwatch to record the time taken to walk the middle 10 meters, and then divides the distance (10 meters) by the time to calculate the walking speed.
Gait ability - Speed (m/s)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Speed (m/s) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - Cadence (steps/minute)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Cadence (steps/minute) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - Stride length (m)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Stride length (m) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - Step length (m)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Step length (m) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - Percentages of stance phase (%)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Percentages of stance phase (%) will be recorded using the commercially available portable gait analysis system (Gait Up)
Gait ability - Percentages of swing phase (%)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Percentages of swing phase (%) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - Gait symmetry (%)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Gait symmetry (%) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - first maximum toe clearance (cm)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The first maximum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - second maximum toe clearance (cm)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The second maximum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Gait ability - minimum toe clearance (cm)
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. The minimum toe clearance (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).
Ankle joint range (degrees) during walking
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. Ankle joint range (degrees) during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
EMG activity (µV) of tibialis anterior during walking
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. EMG activity (µV) of tibialis anterior during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
EMG activity (µV) of gastrocnemius during walking
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
The participant will be asked to walk at a comfortable speed along a 14-meter walkway. EMG activity (µV) of gastrocnemius during walking will be recorded using the commercially wireless system (Delsys Inc., United States).
7 secondary outcomes
Functional reach test
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Timed Up and Go test
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Activities-specific Balance Confidence Scale
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Muscle strength
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Joint range of motion
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Spasticity
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Proprioception
Time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Stroke Gait Rehabilitation
Recruiting
Task-Oriented Training Versus High-Intensity Gait Training in People With Chronic Stroke
Stroke, Hemiplegia
Not yet recruiting
Foot Drop Rehabilitation and Mobility in Chronic Stroke
Stroke
Active, not recruiting
Comparative Effects of Vestibular Rehabilitation With and Without Cervical JPS Training in Stroke Patients
Stroke
RecruitingObservational study
Post-Stroke Apraxia, Motor Function, Balance, and Gait
Stroke, Ideomotor Apraxia
RecruitingObservational study
Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
Stroke, Ideomotor Apraxia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing KT group and Conventional group in people with Stroke Gait Rehabilitation, run by Fooyin University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact I-Hsuan Chen (886-7-7811151 #7043, Y0894@fy.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gait ability - 10 meter walk test (time frame: 1. Baseline (prior to KT application, Day 1) 2. Immediately after KT application (Day 1) 3. 48 hours after KT application (Day 3)). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.